Matches in Nanopublications for { ?s ?p "[Deguelin inhibited survivin expression in tuberous sclerosis complex 2 (TSC2) wild-type mouse embryonic fibroblasts (MEF) but not in TSC2-knockout MEFs in which mammalian target of rapamycin (mTOR) is constitutively active.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP396930.RAqZy7Rm5qa0pekjRyjVOCiY2RESUFCk63xwpy2R37AII130_assertion description "[Deguelin inhibited survivin expression in tuberous sclerosis complex 2 (TSC2) wild-type mouse embryonic fibroblasts (MEF) but not in TSC2-knockout MEFs in which mammalian target of rapamycin (mTOR) is constitutively active.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396930.RAqZy7Rm5qa0pekjRyjVOCiY2RESUFCk63xwpy2R37AII130_provenance.
- assertion description "[Deguelin inhibited survivin expression in tuberous sclerosis complex 2 (TSC2) wild-type mouse embryonic fibroblasts (MEF) but not in TSC2-knockout MEFs in which mammalian target of rapamycin (mTOR) is constitutively active.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP166340.RAHXczcItjfoXBfNjp0_wMVnSFTf_l-QAF5ooGHZ3SRvc130_assertion description "[Deguelin inhibited survivin expression in tuberous sclerosis complex 2 (TSC2) wild-type mouse embryonic fibroblasts (MEF) but not in TSC2-knockout MEFs in which mammalian target of rapamycin (mTOR) is constitutively active.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166340.RAHXczcItjfoXBfNjp0_wMVnSFTf_l-QAF5ooGHZ3SRvc130_provenance.
- NP742648.RA42m39SFEgvcbJWj3FD7UVACvAOeMYMFcc4UBjU77wGM130_assertion description "[Deguelin inhibited survivin expression in tuberous sclerosis complex 2 (TSC2) wild-type mouse embryonic fibroblasts (MEF) but not in TSC2-knockout MEFs in which mammalian target of rapamycin (mTOR) is constitutively active.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP742648.RA42m39SFEgvcbJWj3FD7UVACvAOeMYMFcc4UBjU77wGM130_provenance.
- assertion description "[Deguelin inhibited survivin expression in tuberous sclerosis complex 2 (TSC2) wild-type mouse embryonic fibroblasts (MEF) but not in TSC2-knockout MEFs in which mammalian target of rapamycin (mTOR) is constitutively active.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP645944.RAWE6boB7WBB-yx65TpXspyEXPuZukAF2a4PUYM9-KPV4130_assertion description "[Deguelin inhibited survivin expression in tuberous sclerosis complex 2 (TSC2) wild-type mouse embryonic fibroblasts (MEF) but not in TSC2-knockout MEFs in which mammalian target of rapamycin (mTOR) is constitutively active.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645944.RAWE6boB7WBB-yx65TpXspyEXPuZukAF2a4PUYM9-KPV4130_provenance.
- NP645942.RA6xEqcKjFAF7uWmZL4fcglDGlTjZ6ToZgsPjWBitBFy8130_assertion description "[Deguelin inhibited survivin expression in tuberous sclerosis complex 2 (TSC2) wild-type mouse embryonic fibroblasts (MEF) but not in TSC2-knockout MEFs in which mammalian target of rapamycin (mTOR) is constitutively active.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645942.RA6xEqcKjFAF7uWmZL4fcglDGlTjZ6ToZgsPjWBitBFy8130_provenance.